Industry: Chemical & Material
Published Date: 2026-04-27
Pages: 141 Pages
Report ld: 6640054
Request Sample
Customized Report
The global Copovidone (PVP-VA) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Copovidone (PVP-VA) competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Copovidone, also known as PVP-VA, is a copolymer used as a binder, film-former, and solubilizer in pharmaceutical formulations.
The market for copovidone is driven by its applications in solid oral dosage forms, providing enhanced drug release and solubility. The increasing demand for pharmaceutical excipients and advanced drug formulations further boosts the adoption of copovidone.
This report delivers a comprehensive overview of the global Copovidone (PVP-VA) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Copovidone (PVP-VA). The Copovidone (PVP-VA) market size, estimates, and forecasts are provided in terms of output/shipments (MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Copovidone (PVP-VA) market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Copovidone (PVP-VA) manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Copovidone (PVP-VA) manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Copovidone (PVP-VA) production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Copovidone (PVP-VA) consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Copovidone (PVP-VA) Market Overview
1.1 Product Definition
1.2 Copovidone (PVP-VA) by Type
1.2.1 Global Copovidone (PVP-VA) Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Medical Grade
1.2.3 Food Grade
1.2.4 Industrial Grade
1.3 Copovidone (PVP-VA) by Application
1.3.1 Global Copovidone (PVP-VA) Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Adhesive
1.3.3 Film Former
1.3.4 Other
1.4 Global Market Growth Prospects
1.4.1 Global Copovidone (PVP-VA) Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Copovidone (PVP-VA) Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Copovidone (PVP-VA) Production Estimates and Forecasts (2021–2032)
1.4.4 Global Copovidone (PVP-VA) Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Copovidone (PVP-VA) Production Market Share by Manufacturers (2021–2026)
2.2 Global Copovidone (PVP-VA) Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Copovidone (PVP-VA), Industry Ranking, 2024 vs 2025
2.4 Global Copovidone (PVP-VA) Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Copovidone (PVP-VA) Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Copovidone (PVP-VA), Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Copovidone (PVP-VA), Product Offerings and Applications
2.8 Global Key Manufacturers of Copovidone (PVP-VA), Date of Entry into the Industry
2.9 Copovidone (PVP-VA) Market Competitive Situation and Trends
2.9.1 Copovidone (PVP-VA) Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Copovidone (PVP-VA) Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Copovidone (PVP-VA) Production by Region
3.1 Global Copovidone (PVP-VA) Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Copovidone (PVP-VA) Production Value by Region (2021–2032)
3.2.1 Global Copovidone (PVP-VA) Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Copovidone (PVP-VA) by Region (2027–2032)
3.3 Global Copovidone (PVP-VA) Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Copovidone (PVP-VA) Production Volume by Region (2021–2032)
3.4.1 Global Copovidone (PVP-VA) Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Copovidone (PVP-VA) by Region (2027–2032)
3.5 Global Copovidone (PVP-VA) Market Price Analysis by Region (2021–2032)
3.6 Global Copovidone (PVP-VA) Production, Value, and Year-over-Year Growth
3.6.1 North America Copovidone (PVP-VA) Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Copovidone (PVP-VA) Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Copovidone (PVP-VA) Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Copovidone (PVP-VA) Production Value Estimates and Forecasts (2021–2032)
4 Copovidone (PVP-VA) Consumption by Region
4.1 Global Copovidone (PVP-VA) Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Copovidone (PVP-VA) Consumption by Region (2021–2032)
4.2.1 Global Copovidone (PVP-VA) Consumption by Region (2021–2026)
4.2.2 Global Copovidone (PVP-VA) Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Copovidone (PVP-VA) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Copovidone (PVP-VA) Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Copovidone (PVP-VA) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Copovidone (PVP-VA) Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Copovidone (PVP-VA) Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Copovidone (PVP-VA) Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Copovidone (PVP-VA) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Copovidone (PVP-VA) Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Copovidone (PVP-VA) Production by Type (2021–2032)
5.1.1 Global Copovidone (PVP-VA) Production by Type (2021–2026)
5.1.2 Global Copovidone (PVP-VA) Production by Type (2027–2032)
5.1.3 Global Copovidone (PVP-VA) Production Market Share by Type (2021–2032)
5.2 Global Copovidone (PVP-VA) Production Value by Type (2021–2032)
5.2.1 Global Copovidone (PVP-VA) Production Value by Type (2021–2026)
5.2.2 Global Copovidone (PVP-VA) Production Value by Type (2027–2032)
5.2.3 Global Copovidone (PVP-VA) Production Value Market Share by Type (2021–2032)
5.3 Global Copovidone (PVP-VA) Price by Type (2021–2032)
6 Segment by Application
6.1 Global Copovidone (PVP-VA) Production by Application (2021–2032)
6.1.1 Global Copovidone (PVP-VA) Production by Application (2021–2026)
6.1.2 Global Copovidone (PVP-VA) Production by Application (2027–2032)
6.1.3 Global Copovidone (PVP-VA) Production Market Share by Application (2021–2032)
6.2 Global Copovidone (PVP-VA) Production Value by Application (2021–2032)
6.2.1 Global Copovidone (PVP-VA) Production Value by Application (2021–2026)
6.2.2 Global Copovidone (PVP-VA) Production Value by Application (2027–2032)
6.2.3 Global Copovidone (PVP-VA) Production Value Market Share by Application (2021–2032)
6.3 Global Copovidone (PVP-VA) Price by Application (2021–2032)
7 Key Companies Profiled
7.1 Ashland
7.1.1 Ashland Copovidone (PVP-VA) Company Information
7.1.2 Ashland Copovidone (PVP-VA) Product Portfolio
7.1.3 Ashland Copovidone (PVP-VA) Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 Ashland Main Business and Markets Served
7.1.5 Ashland Recent Developments/Updates
7.2 BASF
7.2.1 BASF Copovidone (PVP-VA) Company Information
7.2.2 BASF Copovidone (PVP-VA) Product Portfolio
7.2.3 BASF Copovidone (PVP-VA) Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 BASF Main Business and Markets Served
7.2.5 BASF Recent Developments/Updates
7.3 Boai Nky Pharmaceuticals
7.3.1 Boai Nky Pharmaceuticals Copovidone (PVP-VA) Company Information
7.3.2 Boai Nky Pharmaceuticals Copovidone (PVP-VA) Product Portfolio
7.3.3 Boai Nky Pharmaceuticals Copovidone (PVP-VA) Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Boai Nky Pharmaceuticals Main Business and Markets Served
7.3.5 Boai Nky Pharmaceuticals Recent Developments/Updates
7.4 Star-Tech & JRS Specialty Products
7.4.1 Star-Tech & JRS Specialty Products Copovidone (PVP-VA) Company Information
7.4.2 Star-Tech & JRS Specialty Products Copovidone (PVP-VA) Product Portfolio
7.4.3 Star-Tech & JRS Specialty Products Copovidone (PVP-VA) Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Star-Tech & JRS Specialty Products Main Business and Markets Served
7.4.5 Star-Tech & JRS Specialty Products Recent Developments/Updates
7.5 Hangzhou Motto Science & Technology
7.5.1 Hangzhou Motto Science & Technology Copovidone (PVP-VA) Company Information
7.5.2 Hangzhou Motto Science & Technology Copovidone (PVP-VA) Product Portfolio
7.5.3 Hangzhou Motto Science & Technology Copovidone (PVP-VA) Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Hangzhou Motto Science & Technology Main Business and Markets Served
7.5.5 Hangzhou Motto Science & Technology Recent Developments/Updates
7.6 Shanghai Yuking Water Soluble Material
7.6.1 Shanghai Yuking Water Soluble Material Copovidone (PVP-VA) Company Information
7.6.2 Shanghai Yuking Water Soluble Material Copovidone (PVP-VA) Product Portfolio
7.6.3 Shanghai Yuking Water Soluble Material Copovidone (PVP-VA) Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Shanghai Yuking Water Soluble Material Main Business and Markets Served
7.6.5 Shanghai Yuking Water Soluble Material Recent Developments/Updates
7.7 JH Nanhang Life Sciences
7.7.1 JH Nanhang Life Sciences Copovidone (PVP-VA) Company Information
7.7.2 JH Nanhang Life Sciences Copovidone (PVP-VA) Product Portfolio
7.7.3 JH Nanhang Life Sciences Copovidone (PVP-VA) Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 JH Nanhang Life Sciences Main Business and Markets Served
7.7.5 JH Nanhang Life Sciences Recent Developments/Updates
7.8 Jiaozuo Zhongwei Special Products Pharmaceutical
7.8.1 Jiaozuo Zhongwei Special Products Pharmaceutical Copovidone (PVP-VA) Company Information
7.8.2 Jiaozuo Zhongwei Special Products Pharmaceutical Copovidone (PVP-VA) Product Portfolio
7.8.3 Jiaozuo Zhongwei Special Products Pharmaceutical Copovidone (PVP-VA) Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 Jiaozuo Zhongwei Special Products Pharmaceutical Main Business and Markets Served
7.8.5 Jiaozuo Zhongwei Special Products Pharmaceutical Recent Developments/Updates
7.9 Huzhou Sunflower Pharmaceutical
7.9.1 Huzhou Sunflower Pharmaceutical Copovidone (PVP-VA) Company Information
7.9.2 Huzhou Sunflower Pharmaceutical Copovidone (PVP-VA) Product Portfolio
7.9.3 Huzhou Sunflower Pharmaceutical Copovidone (PVP-VA) Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 Huzhou Sunflower Pharmaceutical Main Business and Markets Served
7.9.5 Huzhou Sunflower Pharmaceutical Recent Developments/Updates
7.10 Huangshan Bonsun Pharmaceuticals
7.10.1 Huangshan Bonsun Pharmaceuticals Copovidone (PVP-VA) Company Information
7.10.2 Huangshan Bonsun Pharmaceuticals Copovidone (PVP-VA) Product Portfolio
7.10.3 Huangshan Bonsun Pharmaceuticals Copovidone (PVP-VA) Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 Huangshan Bonsun Pharmaceuticals Main Business and Markets Served
7.10.5 Huangshan Bonsun Pharmaceuticals Recent Developments/Updates
7.11 Jiaozuo Meida
7.11.1 Jiaozuo Meida Copovidone (PVP-VA) Company Information
7.11.2 Jiaozuo Meida Copovidone (PVP-VA) Product Portfolio
7.11.3 Jiaozuo Meida Copovidone (PVP-VA) Production, Value, Price, and Gross Margin (2021–2026)
7.11.4 Jiaozuo Meida Main Business and Markets Served
7.11.5 Jiaozuo Meida Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Copovidone (PVP-VA) Industry Chain Analysis
8.2 Copovidone (PVP-VA) Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Copovidone (PVP-VA) Production Modes and Processes
8.4 Copovidone (PVP-VA) Sales and Marketing
8.4.1 Copovidone (PVP-VA) Sales Channels
8.4.2 Copovidone (PVP-VA) Distributors
8.5 Copovidone (PVP-VA) Customer Analysis
9 Copovidone (PVP-VA) Market Dynamics
9.1 Copovidone (PVP-VA) Industry Trends
9.2 Copovidone (PVP-VA) Market Drivers
9.3 Copovidone (PVP-VA) Market Challenges
9.4 Copovidone (PVP-VA) Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Copovidone (PVP-VA) was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 140
USD 3950.00
(Single User License)
The global Copovidone (PVP-VA) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 170
USD 4900.00
(Single User License)
The global Copovidone (PVP-VA) market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 100
USD 4250.00
(Single User License)
The global market for Copovidone (PVP-VA) was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 113
USD 3950.00
(Single User License)
The global market for Copovidone (PVP-VA) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-24
Pages: 99
USD 2900.00
(Single User License)
The global market for Copovidone (PVP-VA) was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 140
The global Copovidone (PVP-VA) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 170
The global Copovidone (PVP-VA) market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 100
The global market for Copovidone (PVP-VA) was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 113
The global market for Copovidone (PVP-VA) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-24
Pages: 99
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now